{"disease":{"id":"obstetric-labour-premature","name":"obstetric labour premature"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02292784","title":"Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02292771","title":"A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":97,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00404768","title":"The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01702376","title":"This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01627587","title":"A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT02377414","title":"Study to Investigate the Pharmacokinetics (PK), Safety and Tolerability of Retosiban in Healthy Japanese Women","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT02377466","title":"A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01867996","title":"A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}